[HTML] frontiersin.org

[HTML][HTML] Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives

M Li, N Xue, X Liu, Q Wang, H Yan, Y Liu… - Frontiers in …, 2021 - frontiersin.org
According to the classical pharmacophore fusion strategy, a series of 6-arylureido-4-
anilinoquinazoline derivatives (Compounds 7a–t) were designed, synthesized, and …
被引用次数：11 相关文章
[HTML] nih.gov

[HTML][HTML] Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives

M Li, N Xue, X Liu, Q Wang, H Yan, Y Liu… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
According to the classical pharmacophore fusion strategy, a series of 6-arylureido-4-
anilinoquinazoline derivatives (Compounds 7a–t) were designed, synthesized, and …

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives

M Li, N Xue, X Liu, Q Wang, H Yan… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
According to the classical pharmacophore fusion strategy, a series of 6-arylureido-4-
anilinoquinazoline derivatives (Compounds 7a-t) were designed, synthesized, and …

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives.

M Li, N Xue, X Liu, Q Wang, H Yan, Y Liu… - Frontiers in …, 2021 - europepmc.org
According to the classical pharmacophore fusion strategy, a series of 6-arylureido-4-
anilinoquinazoline derivatives (Compounds 7a–t) were designed, synthesized, and …